Quest Diagnostics Incorporated
DGX
$173.76
-$2.11-1.20%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.65B | 2.62B | 2.49B | 2.40B | 2.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.65B | 2.62B | 2.49B | 2.40B | 2.37B |
| Cost of Revenue | 1.78B | 1.76B | 1.67B | 1.59B | 1.58B |
| Gross Profit | 869.00M | 866.00M | 816.00M | 808.00M | 784.00M |
| SG&A Expenses | 463.00M | 459.00M | 432.00M | 406.00M | 436.00M |
| Depreciation & Amortization | 39.00M | 37.00M | 32.00M | 29.00M | 29.00M |
| Other Operating Expenses | -1.00M | 2.00M | -1.00M | 1.00M | -1.00M |
| Total Operating Expenses | 2.28B | 2.25B | 2.14B | 2.03B | 2.05B |
| Operating Income | 368.00M | 368.00M | 353.00M | 372.00M | 320.00M |
| Income Before Tax | 294.00M | 304.00M | 302.00M | 314.00M | 274.00M |
| Income Tax Expenses | 59.00M | 68.00M | 65.00M | 74.00M | 66.00M |
| Earnings from Continuing Operations | 235.00M | 236.00M | 237.00M | 240.00M | 208.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -14.00M | -11.00M | -11.00M | -14.00M |
| Net Income | 220.00M | 222.00M | 226.00M | 229.00M | 194.00M |
| EBIT | 368.00M | 368.00M | 353.00M | 372.00M | 320.00M |
| EBITDA | 508.00M | 503.00M | 478.00M | 489.00M | 436.00M |
| EPS Basic | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 |
| Normalized Basic EPS | 1.64 | 1.73 | 1.64 | 1.76 | 1.53 |
| EPS Diluted | 1.94 | 1.98 | 1.99 | 2.03 | 1.72 |
| Normalized Diluted EPS | 1.62 | 1.70 | 1.62 | 1.75 | 1.52 |
| Average Basic Shares Outstanding | 111.00M | 111.00M | 112.00M | 111.00M | 111.00M |
| Average Diluted Shares Outstanding | 113.00M | 113.00M | 113.00M | 112.00M | 112.00M |
| Dividend Per Share | 0.80 | 0.75 | 0.75 | 0.75 | 0.75 |
| Payout Ratio | 38.18% | 37.84% | 37.17% | 36.68% | 40.72% |